METTL7B expression is elevated in lung cancer, and deletion of METTL7B significantly reduces cyclin D1, a key regulator of the G1/S transition, leading to G0/G1 arrest and inhibition of lung cancer proliferation [49]. Here, TMT1B is linked to lung carcinoma.